<DOC>
	<DOCNO>NCT00091429</DOCNO>
	<brief_summary>The study multi-national , double-blind , randomize , placebo-controlled , parallel group study evaluate effectiveness ranolazine ( 1000 mg twice daily ) approximately 500 patient chronic angina remain symptomatic despite daily treatment maximum label dose amlodipine ( 10 mg daily ) , calcium channel blocker approve treatment chronic angina . Eligible patient randomize receive ranolazine 1000 mg placebo twice daily , addition daily dose 10 mg amlodipine . Participation study last approximately 3 month .</brief_summary>
	<brief_title>Ranolazine SR Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Eligible patient must diagnosis chronic angina , document evidence coronary artery disease prior myocardial infarction , addition study entry criterion . Prior enter study , patient require least two week treatment amlodipine 10 mg daily , discontinuation antianginal therapy duration study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Angina</keyword>
	<keyword>Chest Pain</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Heart Disease</keyword>
</DOC>